Microcaps Leading the Late‑Day Charge
DENVER, Colo., Oct 07, 2025 (247marketnews.com)- As the market nears closing, momentum is trending toward biotech, materials, and mining plays.
Among today’s names, Kraig Biocraft Laboratories (OTCQB:KBLB) is drawing intrigue, as it has unlocked mass production of spider silk using genetically engineered silkworms, a solution to the “centuries‑old problem” of farming spiders. With potential applications spanning biomedical, defense, and advanced textiles, KBLB is one to watch into the close and after hours for partnerships, licensing deals, or pilot confirmations.
Meanwhile, NUBURU (NYSE:BURU) is in play following its $12 million public offering aimed at funding acquisitions. The company has already launched a new arm, Nuburu Defense, and is targeting TEKNE S.p.A., a provider of defense and electronic warfare technologies. Any filings or contract announcements related to those acquisitions could spark after-hours movement.
On the resource & infrastructure front, Trilogy Metals (NYSE:TMQ) is riding tailwinds from the U.S. government’s $35.6 million investment into its Alaskan Upper Kobuk Mineral Projects, in coordination with South32 and Ambler Metals. The strategic backing injects national security relevance into TMQ and, by extension, Northern Dynasty Minerals (NYSE:NAK), which shares exposure through the Pebble project in Alaska. Watch for headline derivatives or volume spillover between the two.
Turning to finance & blockchain, Zeta Network (NASDAQ:ZNB) is powering upward on news of a strategic partnership with SOLV Foundation, whereby ZNB will custody its Bitcoin holdings within SOLV’s regulated infrastructure and collaborate on SolvBTC and tokenized real-world assets across blockchains. Zeta also converted convertible debt into equity to clean up its capital structure, moves that may tighten float and fuel volatility into the close.
In the small-cap devices pocket, Envoy Medical (NASDAQ:COCH) is seeing light trade after securing $2.5 million via a registered direct offering and extinguishing $32 million in debt. The company also just earned FDA approval to expand its pivotal trial for the fully implanted Acclaim cochlear implant, shaving months off its expected timeline. Any progress updates on its clinical path or regulatory filings could drive after-hours activity.
C3is (NASDAQ:CISS), a small-cap shipping company spun out of Imperial Petroleum, continues to trade with heightened volatility amid investor speculation. Operating in the drybulk and tanker sectors, C3is controls a modest but active fleet and occasionally sees momentum linked to broader trends in freight rates or oil demand.
For more information about Kraig Labs’ spider silk technology and partnership opportunities, visit www.kraiglabs.com
Please click here to read the full Kraig Labs analyst report on 247marketnews.com.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) is a biotechnology company focused on the development and commercialization of spider silk-based fiber technologies. Through its proprietary silkworm-based genetic engineering platform, Kraig Labs produces high-performance, cost-effective, and scalable spider silk materials for use in defense, performance apparel, technical textiles, and medical applications.
For more information, please visit: www.kraiglabs.com
Contact sales@247marketnews.com for Analyst Report coverage and other investor/public relations services.
PAID EDITORIAL DISCLOSURE: This is a paid editorial communication intended for informational purposes only. 247 is a third-party media provider and has been compensated by one or more featured companies for providing ongoing KBLB market outreach and other services.. This press release may include technical analysis and should not be construed as financial or investment advice. Trading stocks involves risks, and readers should consult with their financial advisor before making investment decisions. Please review 247’s Full Disclaimer https://www.247marketnews.com/disclaimer/. Please go to https://247marketnews.com/kblb-disclosure/ for further KBLB and 247marketnews.com disclosure information.
About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.
CONTACT:
24/7 Market News
Editor@247marketnews.com